158 related articles for article (PubMed ID: 15897531)
1. Impaired fasting glucose and cardiovascular outcomes in postmenopausal women with coronary artery disease.
Kanaya AM; Herrington D; Vittinghoff E; Lin F; Bittner V; Cauley JA; Hulley S; Barrett-Connor E
Ann Intern Med; 2005 May; 142(10):813-20. PubMed ID: 15897531
[TBL] [Abstract][Full Text] [Related]
2. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
[TBL] [Abstract][Full Text] [Related]
3. Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.
Keech A; Colquhoun D; Best J; Kirby A; Simes RJ; Hunt D; Hague W; Beller E; Arulchelvam M; Baker J; Tonkin A;
Diabetes Care; 2003 Oct; 26(10):2713-21. PubMed ID: 14514569
[TBL] [Abstract][Full Text] [Related]
4. Summaries for patients. Are high sugar levels associated with new cardiovascular events in postmenopausal women who have already had a heart attack?
Ann Intern Med; 2005 May; 142(10):I32. PubMed ID: 15897527
[No Abstract] [Full Text] [Related]
5. Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: evidence of a sex difference? The Western New York experience.
Donahue RP; Dorn JM; Stranges S; Swanson M; Hovey K; Trevisan M
Nutr Metab Cardiovasc Dis; 2011 Jul; 21(7):504-11. PubMed ID: 20227262
[TBL] [Abstract][Full Text] [Related]
6. Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).
Rubins HB; Robins SJ; Collins D; Nelson DB; Elam MB; Schaefer EJ; Faas FH; Anderson JW
Arch Intern Med; 2002 Dec 9-23; 162(22):2597-604. PubMed ID: 12456232
[TBL] [Abstract][Full Text] [Related]
7. Fasting plasma glucose predicts survival and angiographic progression in high-risk postmenopausal women with coronary artery disease.
Vaidya D; Kelemen MD; Bittner V; Tardif JC; Thompson P; Ouyang P
J Womens Health (Larchmt); 2007 Mar; 16(2):228-34. PubMed ID: 17388739
[TBL] [Abstract][Full Text] [Related]
8. [Impact of new criterion of glucose level on the prevalence of impaired fasting glucose and risk of ischemic cardiovascular diseases].
Wang W; Zhao D; Sun JY; Liu J; Qin LP; Wu ZS
Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):20-4. PubMed ID: 17331382
[TBL] [Abstract][Full Text] [Related]
9. Metabolic syndrome and cardiovascular disease in older people: The cardiovascular health study.
McNeill AM; Katz R; Girman CJ; Rosamond WD; Wagenknecht LE; Barzilay JI; Tracy RP; Savage PJ; Jackson SA
J Am Geriatr Soc; 2006 Sep; 54(9):1317-24. PubMed ID: 16970637
[TBL] [Abstract][Full Text] [Related]
10. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial.
Kanaya AM; Herrington D; Vittinghoff E; Lin F; Grady D; Bittner V; Cauley JA; Barrett-Connor E;
Ann Intern Med; 2003 Jan; 138(1):1-9. PubMed ID: 12513038
[TBL] [Abstract][Full Text] [Related]
11. The association of fasting glucose levels with congestive heart failure in diabetic adults > or =65 years: the Cardiovascular Health Study.
Barzilay JI; Kronmal RA; Gottdiener JS; Smith NL; Burke GL; Tracy R; Savage PJ; Carlson M
J Am Coll Cardiol; 2004 Jun; 43(12):2236-41. PubMed ID: 15193686
[TBL] [Abstract][Full Text] [Related]
12. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study.
Doi Y; Ninomiya T; Hata J; Fukuhara M; Yonemoto K; Iwase M; Iida M; Kiyohara Y
Stroke; 2010 Feb; 41(2):203-9. PubMed ID: 19940278
[TBL] [Abstract][Full Text] [Related]
13. Glucose levels are associated with cardiovascular disease and death in an international cohort of normal glycaemic and dysglycaemic men and women: the EpiDREAM cohort study.
Anand SS; Dagenais GR; Mohan V; Diaz R; Probstfield J; Freeman R; Shaw J; Lanas F; Avezum A; Budaj A; Jung H; Desai D; Bosch J; Yusuf S; Gerstein HC;
Eur J Prev Cardiol; 2012 Aug; 19(4):755-64. PubMed ID: 21551215
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of abnormal glucose tolerance following a transient ischemic attack or ischemic stroke.
Kernan WN; Viscoli CM; Inzucchi SE; Brass LM; Bravata DM; Shulman GI; McVeety JC
Arch Intern Med; 2005 Jan; 165(2):227-33. PubMed ID: 15668371
[TBL] [Abstract][Full Text] [Related]
15. Pulse pressure and cardiovascular events in postmenopausal women with coronary heart disease.
Nair GV; Chaput LA; Vittinghoff E; Herrington DM;
Chest; 2005 May; 127(5):1498-506. PubMed ID: 15888820
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
Kim SH; Chunawala L; Linde R; Reaven GM
J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
[TBL] [Abstract][Full Text] [Related]
17. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk.
Held C; Gerstein HC; Yusuf S; Zhao F; Hilbrich L; Anderson C; Sleight P; Teo K;
Circulation; 2007 Mar; 115(11):1371-5. PubMed ID: 17339550
[TBL] [Abstract][Full Text] [Related]
18. Relation between the metabolic syndrome and ischemic stroke or transient ischemic attack: a prospective cohort study in patients with atherosclerotic cardiovascular disease.
Koren-Morag N; Goldbourt U; Tanne D
Stroke; 2005 Jul; 36(7):1366-71. PubMed ID: 15933253
[TBL] [Abstract][Full Text] [Related]
19. Long term prognostic implication of newly detected abnormal glucose tolerance among patients with stable cardiovascular disease: a population-based cohort study.
Kabootari M; Asgari S; Ghavam SM; Abdi H; Azizi F; Hadaegh F
J Transl Med; 2021 Jun; 19(1):277. PubMed ID: 34193200
[TBL] [Abstract][Full Text] [Related]
20. Impaired glucose tolerance increases stroke risk in nondiabetic patients with transient ischemic attack or minor ischemic stroke.
Vermeer SE; Sandee W; Algra A; Koudstaal PJ; Kappelle LJ; Dippel DW;
Stroke; 2006 Jun; 37(6):1413-7. PubMed ID: 16627787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
